364 related articles for article (PubMed ID: 31572374)
1. Biased Signaling of CCL21 and CCL19 Does Not Rely on N-Terminal Differences, but Markedly on the Chemokine Core Domains and Extracellular Loop 2 of CCR7.
Jørgensen AS; Larsen O; Uetz-von Allmen E; Lückmann M; Legler DF; Frimurer TM; Veldkamp CT; Hjortø GM; Rosenkilde MM
Front Immunol; 2019; 10():2156. PubMed ID: 31572374
[TBL] [Abstract][Full Text] [Related]
2. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes.
Hauser MA; Legler DF
J Leukoc Biol; 2016 Jun; 99(6):869-82. PubMed ID: 26729814
[TBL] [Abstract][Full Text] [Related]
3. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
[TBL] [Abstract][Full Text] [Related]
4. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
[TBL] [Abstract][Full Text] [Related]
5. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
[TBL] [Abstract][Full Text] [Related]
6. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
[TBL] [Abstract][Full Text] [Related]
8. CCR7 signaling inhibits T cell proliferation.
Ziegler E; Oberbarnscheidt M; Bulfone-Paus S; Förster R; Kunzendorf U; Krautwald S
J Immunol; 2007 Nov; 179(10):6485-93. PubMed ID: 17982037
[TBL] [Abstract][Full Text] [Related]
9. The C-terminal peptide of CCL21 drastically augments CCL21 activity through the dendritic cell lymph node homing receptor CCR7 by interaction with the receptor N-terminus.
Jørgensen AS; Brandum EP; Mikkelsen JM; Orfin KA; Boilesen DR; Egerod KL; Moussouras NA; Vilhardt F; Kalinski P; Basse P; Chen YH; Yang Z; Dwinell MB; Volkman BF; Veldkamp CT; Holst PJ; Lahl K; Goth CK; Rosenkilde MM; Hjortø GM
Cell Mol Life Sci; 2021 Nov; 78(21-22):6963-6978. PubMed ID: 34586443
[TBL] [Abstract][Full Text] [Related]
10. Biased signaling of G protein-coupled receptors - From a chemokine receptor CCR7 perspective.
Jørgensen AS; Rosenkilde MM; Hjortø GM
Gen Comp Endocrinol; 2018 Mar; 258():4-14. PubMed ID: 28694053
[TBL] [Abstract][Full Text] [Related]
11. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
Database (Oxford); 2015; 2015():. PubMed ID: 26504105
[TBL] [Abstract][Full Text] [Related]
12. Chemokines and common variable immunodeficiency; possible contribution of CCL19, CCL21 and CCR7 to immune dysregulation.
Fevang B; Yndestad A; Damås JK; Halvorsen B; Holm AM; Beiske K; Aukrust P; Frøland SS
Clin Exp Immunol; 2009 Nov; 158(2):237-45. PubMed ID: 19747210
[TBL] [Abstract][Full Text] [Related]
13. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
14. ACKR4 Recruits GRK3 Prior to β-Arrestins but Can Scavenge Chemokines in the Absence of β-Arrestins.
Matti C; Salnikov A; Artinger M; D'Agostino G; Kindinger I; Uguccioni M; Thelen M; Legler DF
Front Immunol; 2020; 11():720. PubMed ID: 32391018
[TBL] [Abstract][Full Text] [Related]
15. Heparin Specifically Interacts with Basic BBXB Motifs of the Chemokine CCL21 to Define CCR7 Signaling.
Artinger M; Gerken OJ; Legler DF
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675182
[TBL] [Abstract][Full Text] [Related]
16. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.
Lee J; Park C; Kim HJ; Lee YD; Lee ZH; Song YW; Kim HH
Exp Mol Med; 2017 Jul; 49(7):e358. PubMed ID: 28729639
[TBL] [Abstract][Full Text] [Related]
18. CCR7 Sulfotyrosine Enhances CCL21 Binding.
Phillips AJ; Taleski D; Koplinski CA; Getschman AE; Moussouras NA; Richard AM; Peterson FC; Dwinell MB; Volkman BF; Payne RJ; Veldkamp CT
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841151
[TBL] [Abstract][Full Text] [Related]
19. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
[TBL] [Abstract][Full Text] [Related]
20. Human eosinophils express functional CCR7.
Akuthota P; Ueki S; Estanislau J; Weller PF
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):758-64. PubMed ID: 23449735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
